Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Research Article

Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

S Venkatesan, S M Gerstberger, H Park, S M Holland, Y Nam
S Venkatesan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S M Gerstberger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S M Holland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y Nam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

PubMed 
1433526

Published By 
American Society for Microbiology Journals
History 
  • Published online December 1, 1992.

Author Information

  1. S Venkatesan,
  2. S M Gerstberger,
  3. H Park,
  4. S M Holland and
  5. Y Nam
  1. Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

Article usage

Article usage: November 1999 to January 2021

Rendering graph...
AbstractFullPdf
Nov 1999100
Dec 1999200
Jan 2000100
Feb 2000100
Mar 2000200
Apr 2000100
Oct 2000100
Dec 2000200
Jan 2001400
Mar 2001300
Apr 2001200
Aug 2001100
Oct 2001100
Nov 2001100
Jan 2002100
Feb 2002100
May 2002100
Jul 2002200
Aug 2002100
Sep 2002100
Oct 2002300
Nov 2002100
Dec 2002100
Jul 2003100
Aug 2003300
Sep 2003300
Oct 2003100
Nov 2003500
Dec 2003700
Jan 20041300
Feb 2004900
Mar 2004400
Apr 2004700
May 2004900
Jun 2004500
Jul 2004800
Aug 2004800
Sep 2004800
Oct 2004600
Nov 2004300
Dec 2004100
Jan 2005500
Feb 2005200
Mar 2005200
Apr 2005200
May 2005200
Jun 2005100
Jul 2005200
Aug 2005200
Sep 2005400
Oct 2005200
Nov 2005200
Dec 2005100
Feb 2006200
Mar 2006100
Apr 2006302
May 2006200
Jun 2006101
Jul 2006001
Aug 2006001
Sep 2006201
Oct 2006001
Nov 2006005
Dec 2006407
Mar 2007101
Apr 2007001
May 2007303
Jun 2007001
Jul 2007202
Aug 2007101
Sep 2007002
Oct 2007506
Nov 2007200
Feb 2008100
Mar 2008201
May 2008102
Jun 2008300
Jul 2008500
Aug 2008803
Sep 2008403
Oct 2008101
Nov 2008002
Dec 2008202
Jan 2009202
Feb 2009104
Mar 2009301
Apr 20093087
May 2009101
Jun 2009200
Jul 2009403
Aug 2009100
Sep 2009301
Oct 2009100
Nov 2009200
Jan 2010001
Feb 2010102
Mar 2010201
Apr 2010301
May 2010100
Jun 2010103
Jul 2010204
Aug 2010104
Sep 2010109
Oct 2010203
Nov 2010307
Dec 2010101
Jan 2011203
Feb 2011200
Mar 2011202
Apr 2011201
May 2011406
Jun 2011402
Jul 2011101
Aug 2011304
Sep 2011102
Oct 2011203
Nov 2011302
Dec 2011200
Jan 2012200
Feb 2012402
Mar 2012303
Apr 2012303
May 2012401
Jun 2012301
Jul 2012502
Aug 2012411
Sep 2012204
Oct 20121401
Nov 20121901
Dec 20122202
Jan 20131500
Feb 20132701
Mar 20133102
Apr 20133505
May 2013605
Jun 20131304
Jul 20131000
Aug 2013602
Sep 20131200
Oct 20132303
Nov 20131801
Dec 20131102
Jan 20141402
Feb 20142500
Mar 2014502
Apr 2014301
May 2014502
Jun 2014606
Jul 20141004
Aug 2014901
Sep 20141200
Oct 20142201
Nov 20142403
Dec 20142903
Jan 20152001
Feb 2015403
Mar 2015101
May 2015703
Jun 2015234
Jul 2015211
Aug 2015300
Sep 2015310
Nov 2015003
Dec 20152011
Jan 2016003
Feb 2016001
Mar 2016404
Apr 2016100
May 2016203
Jun 2016204
Jul 2016113
Aug 2016213
Sep 2016627
Oct 2016603
Nov 2016027
Dec 2016112
Jan 2017402
Feb 2017300
Mar 2017301
Apr 2017005
May 2017100
Jun 2017301
Jul 2017102
Aug 2017100
Sep 2017202
Oct 2017302
Nov 2017002
Jan 2018100
Feb 2018100
Apr 2018202
May 2018200
Jun 2018200
Jul 2018001
Aug 2018202
Sep 2018101
Oct 2018101
Nov 2018201
Dec 2018301
Jan 2019301
Mar 2019603
Apr 2019002
May 2019602
Jun 2019002
Jul 2019103
Aug 2019100
Sep 2019102
Oct 2019304
Nov 2019508
Dec 2019308
Jan 2020806
Feb 2020503
Mar 2020205
Apr 2020103
May 2020301
Jun 2020200
Jul 20202505
Aug 2020301
Sep 2020401
Oct 2020804
Nov 2020305
Dec 2020401
Jan 2021301
PreviousNext
Back to top
Download PDF
Citation Tools
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
S Venkatesan, S M Gerstberger, H Park, S M Holland, Y Nam
Journal of Virology Dec 1992, 66 (12) 7469-7480; DOI:

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
S Venkatesan, S M Gerstberger, H Park, S M Holland, Y Nam
Journal of Virology Dec 1992, 66 (12) 7469-7480; DOI:
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514